Chimerix Income Statement

Financials in millions CAD. Fiscal year is December - November.

Millions CAD. Fiscal year is Dec - Nov.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May '25 May 31, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020
Selling, General & Admin	2.97	0.72	0.08	0.22	0.2	0.09
Operating Expenses	3.45	0.92	0.08	0.22	0.2	0.09
Operating Income	-3.51	-0.92	-0.08	-0.22	-0.2	-0.09
Other Non Operating Income (Expenses)	-0.09	-0.08	-0.01	-0.02	-0.03	-
Pretax Income	-3.62	-1	-0.1	-0.24	-0.24	-0.09
Net Income	-3.62	-1	-0.1	-0.24	-0.24	-0.09
Net Income to Common	-3.62	-1	-0.1	-0.24	-0.24	-0.09
Shares Outstanding (Basic)	27	16	11	11	10	3
Shares Outstanding (Diluted)	27	16	11	11	10	3
Shares Change (YoY)	137.49%	37.84%	-	17.89%	240.44%	-
EPS (Basic)	-0.13	-0.06	-0.01	-0.02	-0.02	-0.03
EPS (Diluted)	-0.14	-0.06	-0.01	-0.02	-0.02	-0.03
Free Cash Flow	-3.29	-0.52	-0.09	-0.21	-0.35	-0.13
Free Cash Flow Per Share	-0.12	-0.03	-0.01	-0.02	-0.04	-0.05
EBITDA	-	-0.72	-	-	-	-
D&A For EBITDA	-	0.2	-	-	-	-
EBIT	-3.51	-0.92	-0.08	-0.22	-0.2	-0.09
Advertising Expenses	-	0.03	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.